💡 Strategic acquisition of 95% stake in established diagnostic player to expand into Nashik market.
What Happened
Invicta Diagnostic Limited has announced the acquisition of a majority stake in Vinchurkar Diagnostics Private Limited, a well-established diagnostic services provider based in Nashik. The company will acquire up to 95% equity stake in two tranches, with the first tranche of 51% to be completed by May 31, 2026, and the second tranche of up to 44% by October 31, 2026. The total consideration for the acquisition is ₹7.60 crore.
Key Details
- Company: Invicta Diagnostic Limited
- Event Type: M&A
- Filing Date: 11-Apr-2026 19:18:57
- NSE Filing: View Document
Why It Matters
This acquisition represents Invicta Diagnostic's strategic expansion beyond the Mumbai Metropolitan Region into Nashik, a high-potential healthcare market. Vinchurkar Diagnostics reported a turnover of ₹4.45 crore in FY25 and has been operating since 1993 with comprehensive diagnostic services including CT, MRI, and mammography. The move allows Invicta to leverage an established player's regional presence, operational capabilities, and brand reputation to strengthen its footprint across Maharashtra and drive growth through geographic diversification.
Disclaimer: This is publicly available information sourced from NSE. Not investment advice.
Get signals like this instantly
Free Telegram alerts within 2 minutes of NSE filing
Join SuperStock Free